An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis
- PMID: 19706293
- DOI: 10.1053/j.gastro.2009.08.045
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis
Abstract
Background & aims: Patients with cirrhosis have an increased tendency to develop thromboses despite the longer coagulation times of their plasma, compared with that of healthy individuals. We investigated whether plasma from cirrhotic patients has an imbalance of pro- vs anti-coagulation factors.
Methods: We analyzed blood samples from 134 cirrhotic patients and 131 healthy subjects (controls) for levels of pro- and anti-coagulants and for thrombin generation in the presence or absence of thrombomodulin (the main physiologic activator of the protein C anticoagulant pathway).
Results: The median ratio of thrombin generation (with/without thrombomodulin) was higher in patients (0.80; range, 0.51-1.06) than controls (0.66; range, 0.17-0.95), indicating that cirrhotic patients are resistant to the action of thrombomodulin. This resistance resulted in greater hypercoagulability of plasma from patients of Child-Pugh class C than of class A or B. The hypercoagulability of plasma from patients of Child-Pugh class C (0.86; range, 0.70-1.06) was slightly greater than that observed under the same conditions in patients with congenital protein C deficiency (0.76; range, 0.60-0.93). Levels of factor VIII, a potent pro-coagulant involved in thrombin generation, increased progressively with Child-Pugh score (from Child-Pugh class A to C). Levels of protein C, one of the most potent naturally occurring anti-coagulants, showed the opposite trend.
Conclusions: The hypercoagulability of plasma from patients with cirrhosis appears to result from increased levels of factor VIII and decreased levels of protein C-typical features of patients with cirrhosis. These findings might explain the risk for venous thromboembolism in patients with chronic liver disease.
Similar articles
-
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method.Hepatology. 2010 Jul;52(1):249-55. doi: 10.1002/hep.23653. Hepatology. 2010. PMID: 20578143
-
Procoagulant imbalance in patients with non-alcoholic fatty liver disease.J Hepatol. 2014 Jul;61(1):148-54. doi: 10.1016/j.jhep.2014.03.013. Epub 2014 Mar 18. J Hepatol. 2014. PMID: 24657400
-
Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis.Thromb Haemost. 2010 Oct;104(4):741-9. doi: 10.1160/TH10-01-0040. Epub 2010 Aug 30. Thromb Haemost. 2010. PMID: 20806106
-
Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.Thromb Haemost. 2017 May 3;117(5):830-836. doi: 10.1160/TH16-10-0806. Epub 2017 Feb 23. Thromb Haemost. 2017. PMID: 28229158 Review.
-
Overview of the postulated mechanisms linking cancer and thrombosis.Pathophysiol Haemost Thromb. 2008;36(3-4):122-30. doi: 10.1159/000175150. Epub 2009 Jan 27. Pathophysiol Haemost Thromb. 2008. PMID: 19176985 Review.
Cited by
-
Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis.Med Sci Monit. 2012 Aug;18(8):HY37-41. doi: 10.12659/msm.883252. Med Sci Monit. 2012. PMID: 22847208 Free PMC article.
-
A brief history of liver transplantation and transplant anesthesia.BMC Anesthesiol. 2022 Nov 26;22(1):363. doi: 10.1186/s12871-022-01904-1. BMC Anesthesiol. 2022. PMID: 36435747 Free PMC article. Review.
-
Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation.Dig Dis Sci. 2013 Jun;58(6):1776-80. doi: 10.1007/s10620-012-2548-y. Epub 2013 Jan 12. Dig Dis Sci. 2013. PMID: 23314858
-
Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.Biomed Res Int. 2013;2013:856754. doi: 10.1155/2013/856754. Epub 2013 Feb 21. Biomed Res Int. 2013. PMID: 23555099 Free PMC article.
-
Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study.J Thromb Haemost. 2015 Jul;13(7):1245-53. doi: 10.1111/jth.13000. Epub 2015 Jun 15. J Thromb Haemost. 2015. PMID: 25955079 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical